Value of serum Mac-2 binding proteoglycan isomerin diagnosing liver fibrosis in patients with type 2 diabetes mellitus

LI Jun; CHEN Hongdong; TAN Fang; PAN Huichai; XU Xiaoqing; ZHU Qingwen

doi:10.7619/jcmp.20214730

Journal of Clinical Medicine in Practice > 2022 > 26(7): 109-113. > DOI: 10.7619/jcmp.20214730

LI Jun, CHEN Hongdong, TAN Fang, PAN Huichai, XU Xiaoqing, ZHU Qingwen. Value of serum Mac-2 binding proteoglycan isomerin diagnosing liver fibrosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 109-113. DOI: 10.7619/jcmp.20214730

Citation:

PDF (926 KB)

Value of serum Mac-2 binding proteoglycan isomerin diagnosing liver fibrosis in patients with type 2 diabetes mellitus

Department of Endocrinology, Beijing Hepingli Hospital, Beijing, 100000

More Information

Received Date: November 30, 2021
Available Online: April 05, 2022
Published Date: April 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To explore value of serum Mac-2 binding proteoglycan isomer(M2BPGi) in diagnosing liver fibrosis in patients with type 2 diabetes mellitus(T2DM).
Methods A total of 272 patients diagnosed as T2DM were recruited as study objects, and were divided into T2DM combined with NAFLD group with 122 patients[non-alcoholic fatty liver disease (NAFLD)]and T2DM group[150 T2DM patients without NAFLD]. In addition, serum samples from 150 healthy volunteers(normal control group) who underwent physical examinations in our hospital at the same time were collected as normal controls. According to different NAFLD fibrosis scores, T2DM patients combined with NAFLD were divided into liver fibrosis free subgroup (n=44), uncertain subgroup (n=42), and liver fibrosis subgroup (n=36). Chemiluminescence enzyme immunoassay was used to analyze the level of serum M2BPGi. The levels of laboratory examination indexes in each group were compared. Spearman rank correlation test was used to analyze the correlations of all indicators, and receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum M2BPGi for NAFLD in T2DM patients and for liver fibrosis of T2DM patients with NAFLD.
Results The serum M2BPGi in the T2DM combined with NAFLD group was significantly higher than that in the T2DM group and normal control group (P < 0.001). The area under the curve (AUC) of serum M2BPGi in diagnosis of T2DM combined with NAFLD was 0.919 (95%CI, 0.885 to 0.954). Four indicators of liver fibrosis[hyaluronic acid (HA), laminin (LN), procollagen type Ⅲ (PC-Ⅲ) and collagen type Ⅳ (Ⅳ-C)]and serum M2BPGi levels in the liver fibrosis subgroup were higher than those in the liver fibrosis free subgroup and the uncertain subgroup, and the above indicators of the uncertain subgroup were higher than those of the liver fibrosis free subgroup, the differences were statistically significant (P < 0.05). ROC curve analysis showed that AUC of serum M2BPGi in diagnosis of liver fibrosis in T2DM patients with NAFLD was 0.993 (95%CI, 0.983 to 1.000), which was higher than the value for AUC diagnosed by HA, LN, PC Ⅲ or Ⅳ-C alone. Serum M2BPGi levels of patients with T2DM and NAFLD were positively correlated with HA, LN, PC Ⅲ and Ⅳ-C (r=0.741, 0.835, 0.851, 0.867, P < 0.05).
Conclusion The level of serum M2BPGi in T2DM patients with NAFLD are generally elevated, and its level is associated with progression of liver fibrosis. M2BPGi is expected to be a novel marker for evaluating the progression of liver fibrosis in patients with T2DM complicated with NAFLD.
- Mac-2 binding proteoglycan isomers,
- type 2 diabetes,
- non-alcoholic fatty liver,
- liver fibrosis,
- diagnostic efficiency

FullText(HTML)

References (18)

References

[1]	史丽伟, 倪青, 冯玲, 等. 中医对2型糖尿病合并非酒精性脂肪肝的认识和展望[J]. 辽宁中医杂志, 2019, 46(1): 208-212. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201901069.htm
[2]	吴苏豫, 李江雁, 赵建林, 等. 有氧间歇训练结合利拉鲁肽对老年2型糖尿病合并非酒精性脂肪肝患者肝脏脂肪沉积及抗氧化能力的影响[J]. 中国老年学杂志, 2021, 41(3): 488-490. doi: 10.3969/j.issn.1005-9202.2021.03.011
[3]	NAH E H, CHO S, KIM S, et al. Diagnostic performance of Mac-2 binding protein glycosylation isomer (M2BPGi) in screening liver fibrosis in health checkups[J]. J Clin Lab Anal, 2020, 34(8): e23316.
[4]	MAK L Y, WONG D K H, CHEUNG K S, et al. Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection[J]. Clin Transl Gastroenterol, 2018, 9(6): 163. doi: 10.1038/s41424-018-0020-9
[5]	中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018更新版)[J]. 中华肝脏病杂志, 2018, 26(3): 188-194. doi: 10.3760/cma.j.issn.1007-3418.2018.03.007
[6]	中华医学会内分泌学分会, 中华医学会糖尿病学分会. 中国成人2型糖尿病合并非酒精性脂肪性肝病管理专家共识[J]. 中华内分泌代谢杂志, 2021, 37(7): 589-598. doi: 10.3760/cma.j.cn311282-20210105-00016
[7]	RHEE E J. Nonalcoholic fatty liver disease and diabetes: an epidemiological perspective[J]. Endocrinol Metab (Seoul), 2019, 34(3): 226-233. doi: 10.3803/EnM.2019.34.3.226
[8]	DEWIDAR B, KAHL S, PAFILI K, et al. Metabolic liver disease in diabetes - From mechanisms to clinical trials[J]. Metabolism, 2020, 111S: 154299.
[9]	BRUNNER K T, HENNEBERG C J, WILECHANSKY R M, et al. Nonalcoholic fatty liver disease and obesity treatment[J]. Curr Obes Rep, 2019, 8(3): 220-228. doi: 10.1007/s13679-019-00345-1
[10]	NAGAOKA K, TANAKA M, TANAKA Y. Mac-2 binding protein and its glycan isomer: where does it come from?Where is it going[J]. Hepatol Res, 2021, 51(10): 1026-1028. doi: 10.1111/hepr.13697
[11]	BEHAIRY O G, EL-GENDY S A, IBRAHIM D Y, et al. Mac-2 binding protein glycan isomer as noninvasive tool to assess liver fibrosis in children with chronic liver disease[J]. Hepatol Res, 2021, 51(3): 277-283. doi: 10.1111/hepr.13608
[12]	TSUJI Y, NAMISAKI T, KAJI K, et al. Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B[J]. Exp Ther Med, 2020, 20(2): 985-995. doi: 10.3892/etm.2020.8798
[13]	BAUDI I, INOUE T, TANAKA Y. Novel biomarkers of hepatitis B and hepatocellular carcinoma: clinical significance of HBcrAg and M2BPGi[J]. Int J Mol Sci, 2020, 21(3): 949. doi: 10.3390/ijms21030949
[14]	SALEH S A, SALAMA M M, ALHUSSEINI M M, et al. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals[J]. World J Gastroenterol, 2020, 26(21): 2864-2876. doi: 10.3748/wjg.v26.i21.2864
[15]	HASHIMOTO Y, HAMAGUCHI M, KAJI A, et al. Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001189. doi: 10.1136/bmjdrc-2020-001189
[16]	PARK H, JUN D W, PARK H K, et al. Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes[J]. Ann Transl Med, 2020, 8(23): 1583. doi: 10.21037/atm-20-5216
[17]	YANG Y M, KIM S Y, SEKI E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets[J]. Semin Liver Dis, 2019, 39(1): 26-42. doi: 10.1055/s-0038-1676806
[18]	DEWIDAR B, MEYER C, DOOLEY S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11): 1419. doi: 10.3390/cells8111419

[1]	LYU Xin, ZHANG Xiangjun. Effect of somatostatin combined with magnesium sulfate in treatment of severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 28-31. DOI: 10.7619/jcmp.202022008
[2]	ZHU Zhe. Effect of continuous blood purification on the treatment of patients with severe acute pancreatitis complicated with multiple organ dysfunction syndrome and its impact on peripheral blood inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2019, (5): 50-52. DOI: 10.7619/jcmp.201905013
[3]	LI Rongxia, ZHOU Erxia. Effect of psychological nursing and rehabilitation exercise on serum adhesion factor and inflammatory factors in patients with cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2016, (6): 13-15. DOI: 10.7619/jcmp.201606005
[4]	TIAN Bangni, HE Jianhua, HUANG Mei. Effect of octretide and breviscapine on blood rheology and serum inflammatory factors in patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2015, (17): 38-40. DOI: 10.7619/jcmp.201517012
[5]	ZHANG Yi. Effect observation of hemoperfusion combined with continuous veno-venous hemofiltration on treatment of patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2014, (5): 24-26. DOI: 10.7619/jcmp.201405008
[6]	WANG Zilong, WANG Xiaobing. Clinical effect of Qingkailing preparation combined with cephalosporin drugs on treatment of elderly patients with emphysema and its influence on levels of inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2014, (1): 91-94. DOI: 10.7619/jcmp.201401029
[7]	Effect observation of continuous blood purification on treatment of 15 severe acute pancreatitis patients with multiple organ dysfunction syndrome and related nursing[J]. Journal of Clinical Medicine in Practice, 2013, (20): 1-4. DOI: 10.7619/jcmp.201320001
[8]	LV Peihua. Clinical efficacy of bifico in early treatment of severe acute pancreatitis and its influence on inflammatory factors[J]. Journal of Clinical Medicine in Practice, 2013, (19): 17-20. DOI: 10.7619/jcmp.201319006
[9]	LI Peng, LI Jianjun, JIANG Fan. Effect of early immune nutritional support on systemic inflammatory reactions of patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2013, (11): 127-129. DOI: 10.7619/jcmp.201311052
[10]	YING De-qin. Clinical observation of Somatostatin onsevere acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2011, (11): 41-43. DOI: 10.3969/j.issn.1672-2353.2011.11.013

Cited By

Cited by

Periodical cited type(4)

1.	沈利娜，邵海燕，骆晓婷，陈珊. 预防性应用头孢曲松和喹诺酮对高龄前列腺穿刺术患者全身炎症反应综合征的效果比较及影响因素. 中国药物与临床. 2024(05): 298-301 .
2.	王书恒，李九智，高阳，刘彼得，雷鹏. 前列腺增生患者TUPKRP术后发生全身炎症反应综合征的危险因素分析. 保健医学研究与实践. 2024(07): 79-82+108 .
3.	宋先初，刘明勋，蒋智. 次氯酸冲洗液预防经尿道前列腺电切术后感染的临床研究. 系统医学. 2024(22): 75-77 .
4.	甘育涛，陈佳青. 右美托咪定辅助腰硬联合麻醉对老年经尿道前列腺电切术患者应激反应及炎症因子的影响. 药品评价. 2023(06): 769-772 .

Other cited types(0)

Get Citation

PDF

XML

Article views (286) PDF downloads (23) Cited by(4)

Turn off MathJax

Article Contents

Abstract

References

Value of serum Mac-2 binding proteoglycan isomerin diagnosing liver fibrosis in patients with type 2 diabetes mellitus